GL1X · GenesisL1 explorer

Research workbench

Human H7N9 influenza virus haemagglutinin in complex with human receptor analogue lstc

Analyse Human H7N9 influenza virus haemagglutinin in complex with human receptor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4BSE
Type
protein
Length
486 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Haemagglutinin HA1; Haemagglutinin HA2
UniProt
M4YV75
Ligands
NAG, GAL, SIA, SO4
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHaemagglutinin HA1protein3169% helix, 39% strandM4YV75
BHaemagglutinin HA2protein17056% helix, 13% strandM4YV75

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A, B
  • GAL · beta-D-galactopyranose · sugar · chains A
  • SIA · N-acetyl-alpha-neuraminic acid · sugar · chains A
  • SO4 · Sulfate ion · ion · 15 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12330.640.8326empty
21100.480.8021SO4

Interfaces

1 interface between chains.

  • A–B · 3188 Ų buried · 43 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 4BSE · Human H7N9 Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue LSTc · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.